Dare Bioscience (DARE) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Dare Bioscience Revenue Highlights

Latest Revenue (Y)

$1.03B

Latest Revenue (Q)

$152.46K

Main Segment (Y)

License And Collaboration Revenues

Dare Bioscience Revenue by Period

Dare Bioscience Revenue by Year

Date	Revenue	Change
2025-12-31	$1.03B	10529264.27%
2024-12-31	$9.78K	-99.65%
2023-12-31	$2.81M	-71.92%
2022-12-31	$10.00M	100.00%
2021-12-31	-	100.00%
2020-12-31	-	100.00%
2019-12-31	-	100.00%
2018-12-31	-	100.00%
2017-12-31	-	-100.00%
2016-12-31	$766.00K	100.00%
2015-12-31	-	-100.00%
2014-12-31	$80.00K	1233.33%
2013-12-31	$6.00K	-99.04%
2012-12-31	$625.00K	104.92%
2011-12-31	$305.00K	-

Dare Bioscience generated $1.03B in revenue during NA 2025, up 10529264.27% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Dare Bioscience Revenue by Quarter

Date	Revenue	Change
2026-03-31	$152.46K	-85.11%
2025-12-31	$1.02M	45155.35%
2025-09-30	$2.26K	-110.68%
2025-06-30	$-21.17K	-183.27%
2025-03-31	$25.43K	-139.95%
2024-12-31	$-63.65K	-252.66%
2024-09-30	$41.69K	85.81%
2024-06-30	$22.44K	141.22%
2024-03-31	$9.30K	-99.49%
2023-12-31	$1.81M	80.79%
2023-09-30	$1.00M	100.00%
2023-06-30	-	100.00%
2023-03-31	-	100.00%
2022-12-31	-	100.00%
2022-09-30	-	-100.00%
2022-06-30	$10.00M	100.00%
2022-03-31	-	100.00%
2021-12-31	-	100.00%
2021-09-30	-	100.00%
2021-06-30	-	100.00%
2021-03-31	-	100.00%
2020-12-31	-	100.00%
2020-09-30	-	100.00%
2020-06-30	-	100.00%
2020-03-31	-	100.00%
2019-12-31	-	100.00%
2019-09-30	-	100.00%
2019-06-30	-	100.00%
2019-03-31	-	100.00%
2018-12-31	-	100.00%
2018-09-30	-	100.00%
2018-06-30	-	100.00%
2018-03-31	-	-100.00%
2017-12-31	$-1.83M	100.00%
2017-09-30	-	-100.00%
2017-06-30	$642.00K	-46.14%
2017-03-31	$1.19M	55.61%
2016-12-31	$766.00K	100.00%
2016-09-30	-	100.00%
2016-06-30	-	100.00%
2016-03-31	-	100.00%
2015-12-31	-	100.00%
2015-09-30	-	100.00%
2015-06-30	-	100.00%
2015-03-31	-	100.00%
2014-12-31	-	100.00%
2014-09-30	-	-100.00%
2014-06-30	$33.00K	-29.79%
2014-03-31	$47.00K	683.33%
2013-12-31	$6.00K	100.00%
2013-09-30	-	100.00%
2013-06-30	-	100.00%
2013-03-31	-	-

Dare Bioscience generated $152.46K in revenue during Q1 2026, up -85.11% compared to the previous quarter, and up -239.53% compared to the same period a year ago.

Dare Bioscience Revenue Breakdown

Dare Bioscience Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 22	Dec 20
License And Collaboration Revenues	$12.00M	$11.00M	$10.00M	-
Royalty Revenue	-	$18.00K	-	-
Grant	-	-	-	$2.50M

Dare Bioscience's latest annual revenue breakdown by segment (product or service), as of Dec 25: License And Collaboration Revenues (100.00%).

Quarterly Revenue by Product

Product/Service	Mar 26	Jun 25	Mar 25	Sep 24	Sep 23	Sep 22	Jun 22
Reportable Segment	$242.32K	-	-	-	-	-	-
License And Collaboration Revenue	-	$12.80M	$12.80M	$12.80M	-	-	-
License And Collaboration Revenues	-	-	-	-	$11.00M	$10.00M	$10.00M

Dare Bioscience's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Reportable Segment (100.00%).

Dare Bioscience Revenue Breakdown by Country

Quarterly Revenue by Country

Country	Sep 22	Jun 22
License And Collaboration Revenues	$10.00M	$10.00M

Dare Bioscience's latest quarterly revenue breakdown by geography, as of Sep 22: License And Collaboration Revenues (100.00%).

Dare Bioscience Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
DARE	Dare Bioscience	$1.03B	$152.46K
ANL	Adlai Nortye	$5.00M	$2.50M
ADTX	Aditxt	$3.19M	$12.16K
ASBP	Aspire Biopharma	$6.20K	$28.35K
CTXR	Citius Pharmaceuticals	-	$1.67M
AIMD	Ainos	-	$161.00
LPTX	Leap Therapeutics	-	-
ATHA	Athira Pharma	-	-
PALI	Palisade Bio	-	-
HOTH	Hoth Therapeutics	-	-
FBLG	FibroBiologics	-	-

DARE Revenue FAQ

What is Dare Bioscience’s yearly revenue?

Dare Bioscience's yearly revenue for 2025 was $1.03B, representing an increase of 10529264.27% compared to 2024. The company's yearly revenue for 2024 was $9.78K, representing a decrease of -99.65% compared to 2023. DARE's yearly revenue for 2023 was $2.81M, representing a decrease of -71.92% compared to 2022.

What is Dare Bioscience’s quarterly revenue?

Dare Bioscience's quarterly revenue for Q1 2026 was $152.46K, a -85.11% decrease from the previous quarter (Q4 2025), and a 499.58% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $1.02M, a 45155.35% increase from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024). DARE's quarterly revenue for Q3 2025 was $2.26K, a -110.68% decrease from the previous quarter (Q2 2025), and a -94.57% decrease year-over-year (Q3 2024).

What is Dare Bioscience’s revenue growth rate?

Dare Bioscience's revenue growth rate for the last 3 years (2023-2025) was 36589.29%, and for the last 5 years (2021-2025) was 0%.

What are Dare Bioscience’s revenue streams?

Dare Bioscience's revenue streams in c 25 are License And Collaboration Revenues

What is Dare Bioscience’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Dare Bioscience was License And Collaboration Revenues. This segment made a revenue of $12M, representing 100.00% of the company's total revenue.